Cantil

Cantil is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Cantil diminishes gastric acid and pepsin secretion. Cantil also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications.

Medicinal name:
  • Mepenzolate 25 MG Oral Tablet [Cantil]

Cantil - Pharmacology:

Cantil is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon.

Cantil mini report

Cantil NDA
NDA - A product marketed under an approved New Drug Application
Cantil HUMAN PRESCRIPTION DRUG
HUMAN PRESCRIPTION DRUG
Cantil global name
mepenzolate bromide
Start - Stop data
START DATA:
1956-Nov-14
Start - Stop data
STOP DATA
not occurred

Generic name, Overdose, Half Life Cantil, Food Interactions, Chemical, etc..

Cantil see also FDA report

Brand Names containing Mepenzolate